MXRA8 and colorectal carcinoma: The comprehensive evaluation of MXRA8 in four independent CRC cohorts demonstrated high expression of MXRA8 in tumors (compared to normal), in CRC patients with positive lymphatic metastasis (compared to negative lymphatic metastasis), advanced stage, recurrence, and metastasis.